Home » Oxford Bio Abandons Prostate Cancer Vaccine Study
Oxford Bio Abandons Prostate Cancer Vaccine Study
Britain’s Oxford BioMedica said it was closing a mid-stage clinical trial of its cancer vaccine TroVax in U.S. patients with prostate cancer, dealing a further blow to the troubled product.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May